Pimozide Completed Phase 2 Trials for Schizophrenic Disorders Treatment

IndicationsStatusPurposePhase
CompletedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT00374244Efficacy of Pimozide Augmentation for Clozapine Partial Response